High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease

Gut

Volumn 56, Issue 5, 2007, Pages 669-675

  Kotlowski, Roman ^a   Bernstein, Charles N ^b   Sepehri, Shadi ^a   Krause, Denis O ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRULENCE FACTOR;

ARTICLE; BACTERIUM CULTURE; BIOPSY; CLINICAL ARTICLE; COLONOSCOPY; CROHN DISEASE; DNA DETERMINATION; DNA EXTRACTION; DNA SEQUENCE; ENTERITIS; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; MICROBIAL DIVERSITY; PHYLOGENY; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; PHYLOGENY; VIRULENCE; VIRULENCE FACTORS;

EID: 34247500287     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.099796     Document Type: Article

References (37)

1. Koutroubakis IE. Therapy insight: vascular complications in patients with inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol, 2005;2:266-72, .
2. Sartor RB. Role of commensal enteric bacteria in the pathogenesis of immune-mediated intestinal inflammation: lessons from animal models and implications for translational research. J Pediatr Gastroenterol Nutr 2005;40(Suppl 1):S30-1.
3. Rath HC. The role of endogenous bacterial flora: bystander or the necessary prerequisite? Eur J Gastroenterol Hepatol 2003;15:615- 20.
4. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterol 2005;129:827-36.
5. Garcia-Rodriguez LA, Gonzalez-Perez A, Johansson S, et al. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-15.
6. Hume G, Radford-Smith GL. The pathogenesis of Crohn's disease in the 21st century. Pathology 2002;34:561-7.
7. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5-36.
8. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol Nutr 2005;40(Suppl 1):S30-1.
9. Bull TJ, McMinn EJ, Sidi-Boumedine K, et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 2003;41:2915-23.
10. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635-8.
11. Riesenfeld CS, Schloss PD, Handelsman J, et al. Metagenomics: genomic analysis of microbial communities. Annu Rev Genet 2004;38:525-52.
12. Rappe MS, Giovannoni SJ. The uncultured microbial majority. Annu Rev Microbiol 2004;57:369-94.
13. Cardinale M, Brusetti L, Quatrini P, et al. Comparison of different primer sets for use in automated ribosomal intergenic spacer analysis of complex bacterial communities. Appl Environ Microbiol 2004;70:6147-56.
14. Bernstein CN, Nayar G, Hamel A, et al. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J Clin Microbiol 2003;41:4986-90.
15. Clermont O, Bonacorsi S, Bingen E, et al. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
16. Schmidt H, Hensel M. Pathogenicity islands in bacterial pathogenesis. Clin Microbiol Rev 2004;17:14-56.
17. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
18. Machado J, Grimont F, Grimont PA, et al. Identification of Escherichia coli flagellar types by restriction of the amplified fliC gene. Res Microbiol 2000;151:535-46.
19. Lane DJ. 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M, eds. Nucleic acid techniques in bacterial systematics. New York, NY: Wiley, 1991:115-75.
20. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21.
21. Mylonaki M, Rayment NB, Rampton DS, et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inhamm Bowel Dis 2005;11:481-7.
22. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006;55:1760-7.
23. Nystrom T. Not quite dead enough: on bacterial life, culturability, senescence, and death. Arch Microbiol 2001;176:159- 64.
24. Duriez P, Clermont O, Bonacorsi S, et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001;147:1671-6.
25. Nowrouzian FL, Wold AE, Adlerberth I. Escherichia coli strains belonging to phylogenetic group B2 have superior capacity to persist in the intestinal microflora of infants. J Infect Dis 2005;191:1078-83.
26. Nowrouzian FL, Adlerberth I, Wold AE. Enhanced persistence in the colonic microbiota of Escherichia coli strains belonging to phylogenetic group B2: role of virulence factors and adherence to colonic cells. Microbes Infect 2006;8:834-40.
27. Henderson IR, Navarro-Garcia F, Desvaux M, et al. Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004;68:692-744.
28. Henderson IR, Nataro JP. Virulence functions of aulotransporter proteins. Infect Immun 2001;69:1231-43.
29. Parham NJ, Pollard SJ, Desvaux M, et al. Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli. J Clin Microbiol 2005;43:4076-82.
30. Dutta PR, Cappello R, Navarro-Garcia F, et al. Functional comparison of serine protease autotransporters of Enterobacteriaceae. Infect Immun 2002;70:7105-13.
31. Betis F, Brest P, Hofman V, et al. The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect Immun 2003;71:1068-74.
32. Taddei CR, Fasano A, Ferreira AJ, et al. Secreted autotransporter toxin produced by a diffusely adhering Escherichia coli strain causes intestinal damage in animal model assays. FEMS Microbiol Lett 2005;250:263-9.
33. Guignot J, Chaplais C, Coconnier-Polter MH, et al. The secreted autotransporter toxin. Sat, functions as a virulence factor in Afa/Dr diffusely adhering Escherichia coli by promoting lesions in tight junction of polarized epithelial cells. Cell Microbiol 2007;9:204-21.
34. Henderson IR, Czeczulin J, Eslava C, et al. Characterization of pic, a secreted protease of Shigella flexneri and enteroaggregative Escherichia coli. Infect Immun 1999;67:5587-96.
35. Mellies JL, Navarro-Garcia F, Okeke I, et al. EspC pathogenicity island of enteropothogenic Escherichia coli encodes an enterotoxin. Infect Immun 2001;69:315-24.
36. Dozois CM, Dho-Moulin M, Bree A, et al. Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region. Infect Immun 2000;68:4145-54.
37. Bidet P, Bonacorsi S, Clermont O, et al. Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IU96-like domains among Escherichia coli strains of different clinical origins. Infect Immun 2005;73:4081- 7.